Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemia

Am J Hematol. 1984 Jul;17(1):93-6. doi: 10.1002/ajh.2830170113.

Abstract

A 74-year old woman with Ph1-negative chronic myelogenous leukemia (CML) and heterozygous for glucose-6-phosphate dehydrogenase (G6PD) was studied. Both A and B types of G6PD were found in skin. In contrast, white blood cells and platelets showed only a single G6PD type A. These results provide further evidence that Ph1-negative CML has a stem cell origin and develops clonally.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Blood Platelets / enzymology
  • Chromosomes, Human, 21-22 and Y*
  • Clone Cells / enzymology
  • Erythrocytes / enzymology
  • Female
  • Glucosephosphate Dehydrogenase / metabolism
  • Hematopoietic Stem Cells / enzymology*
  • Humans
  • Leukemia, Myeloid / enzymology
  • Leukemia, Myeloid / genetics*

Substances

  • Glucosephosphate Dehydrogenase